文献速递神经肌肉病神经重症与神经感染

2016年波多黎各寨卡病毒感染与未感染相关吉兰-巴雷综合征的临床特征比较

Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016.
PubMed 文献 · JAMA Neurol · 2018-01-01

2016年波多黎各寨卡病毒流行期间,通过前瞻性和回顾性策略识别123例确诊吉兰-巴雷综合征(GBS)患者,其中107例有检测标本,71例有寨卡病毒感染证据、36例无。与无寨卡病毒感染证据的GBS患者相比,有寨卡病毒感染证据者在急性期面肌无力、吞咽困难、呼吸短促、面部感觉异常、脑脊液蛋白升高、入住重症监护室和需要机械通气的比例更高;发病6个月后,眼过度或不足流泪、用杯饮水困难和自述明显疼痛的比例更高。

要点

  • 有寨卡病毒感染证据的GBS患者急性期面肌无力(62.0% vs 27.8%)、吞咽困难(53.5% vs 25.0%)、呼吸短促(46.5% vs 25.0%)更常见。
  • 有寨卡病毒感染证据的GBS患者急性期入住重症监护室(66.2% vs 44.4%)和需要机械通气(31.0% vs 11.1%)的比例更高。
  • 发病6个月后,有寨卡病毒感染证据的GBS患者眼过度或不足流泪(53.6% vs 26.1%)、用杯饮水困难(17.9% vs 0)、自述明显疼痛(27.3% vs 4.3%)更常见。

核心结论

  • 本研究中,与寨卡病毒感染相关的GBS在急性期具有更高的疾病负担,并在急性神经病变期和6个月后更频繁出现颅神经病变。
  • 结果提示GBS的病理生理机制可能在寨卡病毒感染后更为常见。

研究设计与样本

  • 在波多黎各寨卡病毒流行期间,采用前瞻性和回顾性策略识别2016年神经系统疾病发病并住院于波多黎各全部57家非专科医院和2家康复中心的GBS患者。
  • 通过医疗记录审查并使用Brighton Collaboration标准确诊GBS。
  • 对GBS患者的血清、尿液、脑脊液和唾液标本进行实时逆转录聚合酶链反应检测寨卡病毒感染证据,血清和脑脊液还进行IgM酶联免疫吸附试验。
  • 本分析基于公共卫生监测数据,共识别123例确诊GBS病例,其中107例提交了检测标本,71例有寨卡病毒感染证据、36例无。
  • 在神经系统疾病发病6个月后进行电话随访,有寨卡病毒感染证据的60例和无证据的27例参与。

主要发现

  • 123例确诊GBS患者中位年龄54岁(范围4-88岁),男性68例(55.3%)。
  • 有寨卡病毒感染证据的GBS患者相比无证据者,面肌无力(44例[62.0%] vs 10例[27.8%];P < .001)、吞咽困难(38例[53.5%] vs 9例[25.0%];P = .005)、呼吸短促(33例[46.5%] vs 9例[25.0%];P = .03)、面部感觉异常(13例[18.3%] vs 1例[2.8%];P = .03)更频繁。
  • 有寨卡病毒感染证据的GBS患者相比无证据者,脑脊液蛋白水平升高(49例[94.2%] vs 23例[71.9%];P = .008)、入住重症监护室(47例[66.2%] vs 16例[44.4%];P = .03)、需要机械通气(22例[31.0%] vs 4例[11.1%];P = .02)更频繁。
  • 发病6个月后,有寨卡病毒感染证据的GBS患者相比无证据者,更频繁报告眼过度或不足流泪(30例[53.6%] vs 6例[26.1%];P = .03)、用杯饮水困难(10例[17.9%] vs 0例;P = .03)、自述明显疼痛(15例[27.3%] vs 1例[4.3%];P = .03)。

关键数值与推荐

  • GBS诊断使用Brighton Collaboration标准通过医疗记录审查确认。
  • 寨卡病毒感染证据通过实时逆转录聚合酶链反应检测血清、尿液、脑脊液和唾液标本,以及血清和脑脊液IgM酶联免疫吸附试验确定。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The pathophysiologic mechanisms of Guillain-Barré syndrome (GBS) associated with Zika virus (ZIKV) infection may be indicated by differences in clinical features. OBJECTIVE: To identify specific clinical features of GBS associated with ZIKV infection. DESIGN, SETTING, AND PARTICIPANTS: During the ZIKV epidemic in Puerto Rico, prospective and retrospective strategies were used to identify patients with GBS who had neurologic illness onset in 2016 and were hospitalized at all 57 nonspecialized hospitals and 2 rehabilitation centers in Puerto Rico. Guillain-Barré syndrome diagnosis was confirmed via medical record review using the Brighton Collaboration criteria. Specimens (serum, urine, cerebrospinal fluid, and saliva) from patients with GBS were tested for evidence of ZIKV infection by real-time reverse transcriptase-polymerase chain reaction; serum and cerebrospinal fluid were also tested by IgM enzyme-linked immunosorbent assay. In this analysis of public health surveillance data, a total of 123 confirmed GBS cases were identified, of which 107 had specimens submitted for testing; there were 71 patients with and 36 patients without evidence of ZIKV infection. Follow-up telephone interviews with patients were conducted 6 months after neurologic illness onset; 60 patients with and 27 patients without evidence of ZIKV infection participated. MAIN OUTCOMES AND MEASURES: Acute and long-term clinical characteristics of GBS associated with ZIKV infection. RESULTS: Of 123 patients with confirmed GBS, the median age was 54 years (age range, 4-88 years), and 68 patients (55.3%) were male. The following clinical features were more frequent among patients with GBS and evidence of ZIKV infection compared with patients with GBS without evidence of ZIKV infection: facial weakness (44 [62.0%] vs 10 [27.8%]; P < .001), dysphagia (38 [53.5%] vs 9 [25.0%]; P = .005), shortness of breath (33 [46.5%] vs 9 [25.0%]; P = .03), facial paresthesia (13 [18.3%] vs 1 [2.8%]; P = .03), elevated levels of protein in cerebrospinal fluid (49 [94.2%] vs 23 [71.9%]; P = .008), admission to the intensive care unit (47 [66.2%] vs 16 [44.4%]; P = .03), and required mechanical ventilation (22 [31.0%] vs 4 [11.1%]; P = .02). Six months after neurologic illness onset, patients with GBS and evidence of ZIKV infection more frequently reported having excessive or inadequate tearing (30 [53.6%] vs 6 [26.1%]; P = .03), difficulty drinking from a cup (10 [17.9%] vs 0; P = .03), and self-reported substantial pain (15 [27.3%] vs 1 [4.3%]; P = .03). CONCLUSIONS AND RELEVANCE: In this study, GBS associated with ZIKV infection was found to have higher morbidity during the acute phase and more frequent cranial neuropathy during acute neuropathy and 6 months afterward. Results indicate GBS pathophysiologic mechanisms that may be more common after ZIKV infection.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Dirlikov E, Major CG, Medina NA, et al. Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016. JAMA Neurol. 2018. PMID: 29799940. doi:10.1001/jamaneurol.2018.1058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。